c-myc, N-myc and L-myc are the three members of the myc oncoprotein family
whose role in the pathogenesis of many human neoplastic diseases has receiv
ed wide empirical support. In this review, we first summarize data, derived
mainly from non-clinical studies, indicating that these oncoproteins actua
lly serve quite different roles in vivo. This concept necessarily lies at t
he heart of the basis for the observation that the deregulated expression o
f each MYC gene is reproducibly associated with only certain naturally occu
rring malignancies in humans and that these genes are not interchangeable w
ith respect to their aberrant functional consequences. We also review evide
nce implicating each of the above MYC genes in specific neoplastic diseases
and have attempted to identify unresolved questions which deserve further
basic or clinical investigation. We have made every attempt to review those
diseases for which significant and confirmatory evidence, based on studies
with primary tumor material, exists to implicate MYC members in their caus
ation and/or progression.